Perrigo (PRGO) Other Operating Expenses (2012 - 2026)
Perrigo's (PRGO) quarterly Other Operating Expenses came in at $483.1 million in Q1 2026, up 738.72% year-on-year from $57.6 million in Q1 2025, and down 67.75% on a QoQ basis from $1.5 billion in Q4 2025.
Perrigo (PRGO) Other Operating Expenses (2012 - 2026) Analysis & Trends
Perrigo (PRGO) has 14 years of Other Operating Expenses data on file, last reported at $483.1 million in Q1 2026.
- On a quarterly basis, Other Operating Expenses rose 738.72% year-over-year to $483.1 million in Q1 2026; TTM through Mar 2026 was $2.2 billion, a 6659.45% increase from a year earlier, with the FY2025 full-year figure at $2.0 billion, up 33658.33% from the prior year.
- Other Operating Expenses for Q1 2026 stood at $483.1 million, down from $1.5 billion in the prior quarter.
- Over the last five years, Other Operating Expenses for PRGO reached as high as $1.5 billion in Q4 2025 and fell as low as -$297.2 million in Q4 2024.
- Historically, Other Operating Expenses has averaged $257.6 million across 5 years, with a median of $164.3 million in 2024.
- Across the five-year window, Other Operating Expenses sank 144.73% in 2024 and soared 738.72% in 2026, its largest moves.
- Year by year, Other Operating Expenses stood at $522.9 million in 2022, then advanced by 27.06% to $664.4 million in 2023, then sank by 144.73% to -$297.2 million in 2024, then soared by 604.04% to $1.5 billion in 2025, then slumped by 67.75% to $483.1 million in 2026.
- Per Business Quant data, the three most recent Other Operating Expenses figures were $483.1 million in Q1 2026, $1.5 billion in Q4 2025, and $62.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn |
| 10 | Perrigo | 1.40 Bn | 1.04 Bn | 325.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 483.10 Mn |
| Dec 31, 2025 | 1.50 Bn |
| Sep 27, 2025 | 62.20 Mn |
| Jun 28, 2025 | 173.80 Mn |
| Mar 29, 2025 | 57.60 Mn |
| Dec 31, 2024 | -297.20 Mn |
| Sep 28, 2024 | 164.30 Mn |
| Jun 29, 2024 | 108.10 Mn |
| Mar 30, 2024 | 87.90 Mn |
| Dec 31, 2023 | 664.40 Mn |
| Sep 30, 2023 | 57.40 Mn |
| Jul 1, 2023 | 199.70 Mn |
| Apr 1, 2023 | 195.80 Mn |
| Dec 31, 2022 | 522.90 Mn |
| Oct 1, 2022 | 60.30 Mn |
| Jul 2, 2022 | 180.20 Mn |
| Apr 2, 2022 | 160.90 Mn |
| Dec 31, 2020 | -122.30 Mn |
| Sep 26, 2020 | 22.20 Mn |
| Jun 27, 2020 | 2.10 Mn |